Objectives To examine the prevalence of mental health treatment among nursing home (NH)
long-stay residents with Alzheimer's disease and related dementias (ADRD) and explore …

Abstract Background The Centers for Medicare & Medicaid Services implemented the
National Partnership to Improve Dementia Care in Nursing Homes (the Partnership) to …

Objectives We examined the association between nursing home (NH) characteristics and
whether NHs had high or low levels of antipsychotic, benzodiazepine, or opioid prescribing …

Objectives Following the 2012 launch of the National Partnership to Improve Dementia Care
in Nursing Homes (the National Partnership), the use of antipsychotics has declined …

Abstract Objective The Centers for Medicare and Medicaid Services' National Partnership to
Improve Dementia Care in Nursing Homes focuses on but is not limited to long-term care …

Objectives Assess prevalence of serious mental illness (SMI) alone, and co-occurring with
Alzheimer disease and related dementias (ADRD), among Medicare beneficiaries in …

In nursing homes (NHs), the ability to provide comprehensive psychiatric and behavioral
health care including evidence-based medication prescribing has been outpaced by the …

Objectives Nursing home (NH) staff often report not having adequate dementia-specific
knowledge to effectively care for these residents. Between 2011 and 2019, 9 states in the …

Abstract Background In July 2012, the Centers for Medicare & Medicaid services launched
an antipsychotic reduction initiative (ARI) to improve care for nursing facility residents with …

Objectives To assess changes in behavioral symptoms associated with Alzheimer's disease
and related dementias (ADRD s) after antipsychotic (AP) or antidepressant (AD) treatment …